1 – 15 of 23
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Faecal levels of calprotectin in systemic sclerosis are stable over time and are higher compared to primary Sjogren's syndrome and rheumatoid arthritis
(
- Contribution to journal › Article
- 2013
-
Mark
COMP-C3b Complexes in Rheumatoid Arthritis with Severe Extraarticular Manifestations.
(
- Contribution to journal › Article
-
Mark
Reumatologisk forskning i Lund/Malmö
(
- Contribution to specialist publication or newspaper › Newspaper article
- 2012
-
Mark
Sick leave in patients with ankylosing spondylitis before and after anti-TNF therapy: a population-based cohort study.
(
- Contribution to journal › Article
- 2011
-
Mark
Delays in assessment of patients with rheumatoid arthritis: variations across Europe
(
- Contribution to journal › Article
-
Mark
Increased cartilage turnover and circulating autoantibodies in different subsets before the clinical onset of rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Faecal calprotectin: a biomarker of gastrointestinal disease in systemic sclerosis.
(
- Contribution to journal › Article
-
Mark
Ten years with biologics: to whom do data on effectiveness and safety apply?
(
- Contribution to journal › Article
- 2010
-
Mark
Utility-based outcomes made easy: The number needed per QALY gained (NNQ). Observational cohort study from Southern Sweden of TNF blockade in inflammatory arthritis.
(
- Contribution to journal › Article
-
Mark
Rapid and sustained health utility gain in anti-TNF treated inflammatory arthritis. Observational data during seven years in southern Sweden.
(
- Contribution to journal › Article
-
Mark
Decrease in sick leave among patients with rheumatoid arthritis in the first 12 months after start of treatment with tumour necrosis factor antagonists: a population-based controlled cohort study.
(
- Contribution to journal › Article
- 2009
-
Mark
Cancer Risk in Patients With Rheumatoid Arthritis Treated With Anti-Tumor Necrosis Factor alpha Therapies Does the Risk Change With the Time Since Start of Treatment?
(
- Contribution to journal › Article
-
Mark
Differences in Longitudinal Disease and Treatment Characteristics of Patients with Rheumatoid Arthritis Replying and Not Replying to a Postal Questionnaire. Experience from a Biologics Register in Southern Sweden.
(
- Contribution to journal › Article
-
Mark
Bone mineral density in the hand as a predictor for mortality in patients with rheumatoid arthritis.
(
- Contribution to journal › Article
- 2008
-
Mark
Increased serum levels of cartilage oligomeric matrix protein precede the clinical onset of rheumatoid arthritis despite lower levels among smokers
2008) 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals In Arthritis and Rheumatism 58(9). p.289-290(
- Contribution to journal › Published meeting abstract